Literature DB >> 21070211

Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation.

A Fiumara1, R Barone, A Arena, M Filocamo, W Lissens, L Pavone, G Sorge.   

Abstract

Krabbe leukodystrophy (KD) is a neurodegenerative lysosomal disorder caused by mutations in the galactocerebrosidase (GALC) gene. Different clinical forms are described based on the age at onset. In reported series, the early infantile form (EIKD) accounts for more than 90% of the cases. The rarer late onset forms (LOKD) become manifest later than 6 months up to the adult age. We report clinical, imaging, mutational analysis and geographic data in a large cohort of individuals with Krabbe disease examined over a 30-year period. Retrospective analyses of disease onset and long-term follow-up were conducted in 26 KD patients. Molecular analysis was performed in 12 patients and their families. Nine cases had EIKD, and 17 LOKD, accounting for two thirds of our series. No correlation was found between enzymatic activity, onset age and disease progression. Despite common geographical origin, only in a few cases could parental consanguinity be proven. The p.Gly41Ser mutation was associated with longer survival. A wide spectrum of LOKD is found despite similar genotype. Although current knowledge about onset age, residual enzyme activity and molecular analysis still fail to allow the identification of patient candidates for treatment, this information is valuable for long-term outcome prediction and could lead to reconsideration of inclusion criteria for bone marrow transplant (BMT) or other future therapeutic approaches.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070211     DOI: 10.1111/j.1399-0004.2010.01572.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

Review 1.  Treatment for Krabbe's disease: Finding the combination.

Authors:  Christina R Mikulka; Mark S Sands
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.

Authors:  Dae Song Jang; Wenjuan Ye; Tian Guimei; Melani Solomon; Noel Southall; Xin Hu; Juan Marugan; Marc Ferrer; Gustavo H B Maegawa
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 3.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 4.  Krabbe Disease in the Arab World.

Authors:  Hatem Zayed
Journal:  J Pediatr Genet       Date:  2015-03

5.  Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.

Authors:  Daniel Ysselstein; Joshua M Shulman; Dimitri Krainc
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

6.  "Atypical" Krabbe disease in two siblings harboring biallelic GALC mutations including a deep intronic variant.

Authors:  Francesco Nicita; Fabrizia Stregapede; Federica Deodato; Simone Pizzi; Simone Martinelli; Daria Pagliara; Chiara Aiello; Francesca Cumbo; Fiorella Piemonte; Jessica D'Amico; Stefano Pro; Daniela Longo; Silvia Genovese; Marco Tartaglia; Maria L Escolar; Enrico Bertini; Lorena Travaglini
Journal:  Eur J Hum Genet       Date:  2022-05-17       Impact factor: 5.351

7.  Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Authors:  Chris H Hill; Stephen C Graham; Randy J Read; Janet E Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Two Cases of Female Chinese Adult-Onset Krabbe Disease with One Novel Mutation and a Review of Literature.

Authors:  Chengyi Zhang; Zheng Liu; Huiqing Dong
Journal:  J Mol Neurosci       Date:  2020-11-14       Impact factor: 3.444

9.  A high-throughput screening assay using Krabbe disease patient cells.

Authors:  Jameson Ribbens; Grace Whiteley; Hirokazu Furuya; Noel Southall; Xin Hu; Juan Marugan; Marc Ferrer; Gustavo H B Maegawa
Journal:  Anal Biochem       Date:  2012-11-05       Impact factor: 3.365

10.  Newborn screening for Krabbe disease in New York State: the first eight years' experience.

Authors:  Joseph J Orsini; Denise M Kay; Carlos A Saavedra-Matiz; David A Wenger; Patricia K Duffner; Richard W Erbe; Chad Biski; Monica Martin; Lea M Krein; Matthew Nichols; Joanne Kurtzberg; Maria L Escolar; Darius J Adams; Georgianne L Arnold; Alejandro Iglesias; Patricia Galvin-Parton; David F Kronn; Jennifer M Kwon; Paul A Levy; Joan E Pellegrino; Natasha Shur; Melissa P Wasserstein; Michele Caggana
Journal:  Genet Med       Date:  2016-01-21       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.